Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Sansure’s Six Respiratory Pathogens Multiplex Nucleic Acid Diagnostic Kit has received approval
2022-05-17

On May 12, the Six Respiratory Pathogens Multiplex Nucleic Acid Diagnostic Kit (Multiplex PCR-Fluorescence Probing) developed by Sansure Biotech was approved for marketing (GXZZ 20223400597). It is the first domestic test reagent based on multiplex fluorescence PCR technology to detect six common bacteria in a single tube, and is also a revolutionary product for molecular diagnosis, adding to Sansure Biotech’ […]

LEARN MORE
The first in China! Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit of Sansure Biotech Certified by UK CTDA
2022-05-06

Recently, the Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) developed by Sansure Biotech has got UK CTDA approval, and before that, MHRA registration was completed for this product, meaning that the kits could be marketed in the UK legally. This is the first COVID-19 molecular testing reagent approved in China after the UK government implemented the new registration […]

LEARN MORE
Sansure Biotech donated HK$6.3 million of Covid-19 antigen tests to support Hong Kong
2022-04-22

The epidemic in Hong Kong has touched people’s hearts. With the sincere care for our compatriots in Hong Kong, on the morning of April 20, Sansure Biotech donated HK$6.3 million of Covid-19 antigen tests to the channel of Chinese Culture Foundation and Hunan Charity Federation for the prevention and control of the epidemic in Hong Kong schools, helping Hong Kong […]

LEARN MORE
Breaking News! Sansure Biotech’s SARS-CoV-2 Rapid Antigen Test (Self-testing) Obtains CE 1434 Certificate
2022-04-14

On April 13, the SARS-CoV-2 Rapid Antigen Test (Self-testing) developed by Sansure Biotech has obtained the CE 1434 certificate, which means that the self-test kit can be distributed in EU countries and countries that recognize the EU CE certification. SARS-CoV-2 antigen test is an important means of epidemic prevention and control, which can be used as an auxiliary diagnosing method of […]

LEARN MORE
Sansure Biotech’s Respiratory Adenovirus DNA Diagnostic Kit was approved for marketing
2022-03-10

The Respiratory Adenovirus DNA Diagnostic Kit (PCR-Fluorescence Probing) developed by Sansure was approved for marketing lately, adding another powerful tool to its total solution of respiratory nucleic acid test. Adenovirus, an easily neglected but dangerous respiratory infection pathogen Why is it dangerous and easily neglected? This is because adenovirus is also a virus that is strongly associated with respiratory diseases and […]

LEARN MORE
1 2 3 5
×
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.
SUBMIT

Thank you!

We shall contact you soon!